Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy
Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy
The aim of the study is to examine the suitability, the so-called validation, of a
 questionnaire, with which one can grasp the reasons why injections of growth hormones are
 omitted by patients ("non-adherence"). Participants are treated with growth hormone and are
 therefore eligible to take part in the study. Study doctor will ask participants to answer
 questionnaires. two times within 14 days. The first time participants answer during the
 routine visit to the practice / clinic and the second time at home. There are no risks
 associated with participating in the study as it does not affect participant's medical
 treatment.
Inclusion Criteria: - Children/adolescents, male or female, aged 8 to 18 years who
 self-inject GH as well as their parents/legal guardians or Parents/Legal guardians who
 administer GH to a child/adolescent, male or female, from birth to 18 years - The
 child/adolescent is on prescribed daily GHT due to idiopathic growth hormone deficiency
 (GHD), multiple pituitary hormone deficiency (MPHD/organic GHD), small for gestational age
 (SGA) or Turner syndrome (TS) for at least 6 months before screening visit - Signed
 informed consent obtained by parent/legal guardian and child/adolescent before any
 study-related activities (study-related activities are any procedure related to recording
 of data according to the protocol) Exclusion Criteria: - Mental incapacity, unwillingness
 or language barrier of participant precluding adequate understanding or cooperation -
 Previous participation of participant in this study. Participation is defined as having
 given informed consent in this study - Treatment of child/adolescent with any
 investigational drug within 30 days prior to enrolment into the study